Purchase Order 75F40120P00080
- Not listed
- This firm fixed price purchase order was awarded by the Food and Drug Administration (FDA) to The University of Texas Southwestern Medical Center (UT Southwestern) in Dallas, Texas, for $135,450.00. The contract is for microRNA sequencing validation and confirmation services. UT Southwestern is a component of the University of Texas System, which has extensive experience providing medical research, education, and clinical services to federal agencies like the Department of Veterans Affairs and...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to The University of Texas Southwestern Medical Center (UT Southwestern), a prominent academic medical center and component of the University of Texas System. The $11,050.00 contract is for miRNA sequencing services, with a period of performance through July 24, 2015. The award does not have any set-aside designation. UT Southwestern is an experienced provider of medical research, clinical trials, and...
- This is a firm fixed price contract awarded by the Food and Drug Administration (FDA) to the University of Texas Southwestern Medical Center (UT Southwestern) to perform next-generation sequencing analysis of microRNA expression on 150 rat liver samples. The purpose is to integrate the genomics data with phenotypic and pathological data to support regulatory scientific research through precision medicine. The contract has a ceiling value of $99,750 and does not utilize any set-aside...
- This firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to The University of Texas Southwestern Medical Center (UT Southwestern) for DNA target gene capture and library construction services. The contract has a ceiling value of $149,500.00 and a period of performance ending on September 30, 2017. UT Southwestern, a non-profit educational institution, has extensive experience as both a prime contractor and subcontractor on federal contracts and grants with...
- This is a $180,250 firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to The University of Texas Southwestern Medical Center (UT Southwestern) for targeted gene sequencing of 200 genomic DNA samples from cancer patients. The contract has no set-aside designation. UT Southwestern, an academic medical center that has experience providing specialty medical services and research support to federal agencies, will perform the targeted...
- This federal contract award was issued by the Department of Health and Human Services Food and Drug Administration to The University of Texas Southwestern Medical Center (UT Southwestern) located in Dallas, Texas. The contract is for the Sequence Genomic DNA requirement, with a firm fixed price of $226,609.80 and a completion date of March 31, 2018. The contract did not have a set-aside designation. UT Southwestern is an academic medical center and component of the University of Texas System...
- This firm fixed price Purchase Order was awarded by the U.S. Department of Health and Human Services (HHS) to The University of Texas Southwestern Medical Center (UT Southwestern), a non-profit academic medical center, for $6,000.00 to provide microarray services. The award has no set-aside designation. UT Southwestern, which is a component of the University of Texas System, has a long history of providing a variety of medical and research services to federal agencies, including the Department...
- The University of Texas Southwestern Medical Center (UT Southwestern), located in Dallas, Texas, was awarded a $193,200 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to perform droplet digital PCR (ddPCR) analysis on 12 high quality genomic DNA samples. The analysis will provide orthogonal verification of 400 point mutations discovered through next-generation sequencing tests, which will help assess the analytical performance of...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to The University of Texas Southwestern Medical Center (UT Southwestern) for $4,800.00. The contract is for auto-antibody microarray profiling services to be performed at UT Southwestern's location in Dallas, Texas. The award did not use a set-aside designation. UT Southwestern is a...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to the University of Texas Health Science Center at Houston (UTHealth) for library prep and next generation genome sequencing of influenza A virus. The contract has a potential value of $17,800.00 and a completion date of February 20, 2018. UTHealth is a U.S. Government Entity registered as an Educational...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to the University of Texas Southwestern Medical Center, a non-profit educational institution, for next-generation sequencing analysis of microRNA expression on commercially available human hepatic cell lines and bioinformatic data analysis to identify microRNAs associated with drug-induced liver injury. The contract, which does not have a set-aside designation, has a potential value of $148,500.00 and a completion date of June 17, 2021. The University of Texas Southwestern Medical Center is a component of the University of Texas System, a state university system that has previously received federal grant funding for research across diverse areas.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Next-generation sequencing analysis of microRNA expression on 200 samples from commercially available human hepatic cell lines, and bioinformatic analysis of data to identify miRNAs associated with drug-induced liver injury | 1222579 | Department of Health and Human Services Food and Drug Administration | Pre-Solicitation 1/2 | 12/4/19, 3:40 PM | |
Next-generation sequencing analysis of microRNA expression on 200 samples from commercially available human hepatic cell lines, and bioinformatic analysis of data to identify miRNAs associated with drug-induced liver injury | 1222579 | Department of Health and Human Services Food and Drug Administration | Solicitation 2/2 | 1/21/20, 4:47 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 3/29/21 | |
| Not listed | Not listed | $148.5k | 6/17/20 |